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exosomes
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Joan Seguí-Barber1, Nuria Izquierdo-Useros2,3, Javier Martinez-Picado2,4,5,  
Carmen Fernández-Becerra1,3 & Hernando A. del Portillo  1,3,5
Reticulocyte-derived exosomes (Rex), extracellular vesicles of endocytic origin, were initially 
discovered as a cargo-disposal mechanism of obsolete proteins in the maturation of reticulocytes into 
erythrocytes. In this work, we present the first mass spectrometry-based proteomics of human Rex 
(HuRex). HuRex were isolated from cultures of human reticulocyte-enriched cord blood using different 
culture conditions and exosome isolation methods. The newly described proteome consists of 367 
proteins, most of them related to exosomes as revealed by gene ontology over-representation analysis 
and include multiple transporters as well as proteins involved in exosome biogenesis and erythrocytic 
disorders. Immunoelectron microscopy validated the presence of the transferrin receptor. Moreover, 
functional assays demonstrated active capture of HuRex by mature dendritic cells. As only seven 
proteins have been previously associated with HuRex, this resource will facilitate studies on the role of 
human reticulocyte-derived exosomes in normal and pathological conditions affecting erythropoiesis.
Research on exosomes is gaining momentum as these vesicles of endocytic origin act in intercellular communica-
tion and represent novel therapeutic strategies and non-invasive biomarkers of disease1–3. During their matura-
tion to erythrocytes, reticulocytes selectively remove proteins, noticeably the transferrin receptor (TfR or CD71), 
as well as membrane-associated enzymes, through the formation of multivesicular bodies which after fusion with 
the plasma membrane release intraluminal vesicles, termed exosomes4–6.
Studies on the protein cargo composition of reticulocyte-derived exosomes (Rex) are mostly limited to animal 
models and validations through non high-throughput technologies7–9. These studies clearly established that Rex 
represent a selective cargo disposal mechanism in the terminal maturation of reticulocytes into erythrocytes7. 
More recently, mass spectrometry (MS)-based proteomic analysis of Rex from phenylhydrazine-treated rats10 
and from mice infected with rodent malaria parasites with a unique tropism to reticulocytes11, described the 
proteome of Rex in these species. Results reinforced the view that Rex have selective cargo and demonstrated for 
the first time that Rex from malaria-infected reticulocytes contain parasite antigens involved in antigen presenta-
tion and capable of modulating immune responses11,12. To our knowledge, however, only seven proteins (TfR, 
Stomatin, Flotillin-1 and 2, CD55, CD58 and CD59) have been previously reported in human Rex7,13,14.
In this work, we present the first MS-based proteomic profile of human reticulocyte-derived exosomes 
(HuRex). HuRex were isolated from cultures of human cord blood using two different culture conditions, absence/
presence of exosome-depleted serum, and two different exosome isolation techniques, size-exclusion chromatog-
raphy (SEC) and ultracentrifugation (UC). The proteome consists of 367 proteins most of which have not been 
previously reported. Immunoelectron microscopy validated the presence of the transferrin receptor, a major 
Rex component, and comparative analysis with the MS-datasets from reticulocytes15–17 and mature red blood 
cells17–20, rendered a selected list of HuRex plasma membrane and cytosol proteins. In addition, we identified pro-
teins involved in antigen presentation and observed an active capture of HuRex by mature dendritic cells. These 
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results thus provide a first base-line proteome of HuRex enabling further studies not only on their biogenesis and 
antigen-presenting capacity, but also on their cargo composition in diseases affecting erythropoiesis.
Results
Enrichment of human reticulocytes and in vitro production and characterization of human 
reticulocyte-derived exosomes. Enriched reticulocyte samples were obtained from human blood of 
umbilical cords, a source with higher percentage of reticulocytes than adult humans’ blood and with no major 
proteomic differences between them17. After removal of leukocytes and concentration on Percoll gradients 
(Supplementary Fig. S1), yield percentages of reticulocytes ranged between 20 to 60% among different donors. 
Reticulocytes were subsequently cultured in vitro for 36 h at 1–3% hematocrit. Of note, our cultures contain 
significant percentages of mature red blood cells, yet these cells lack endocytic machinery and it has been clearly 
established that they do not secrete exosomes6,21. Furthermore, we discarded reticulocyte-enriched preparations 
that contained over 2% of contaminating leukocytes to minimize the presence of leukocyte-derived vesicles in 
the cultures. We refrained from using CD71 affinity bead purification as there is a large heterogeneous population 
of reticulocytes from CD71negative to CD71high22. HuRex were produced in vitro in the presence or absence of 
serum, previously depleted of exosomes, as there is evidence suggesting that the protein cargo varies significantly 
in the absence of serum23. Before and after culture, cell viability was assessed by microscopy using Trypan Blue 
stain. We demonstrated 95.6 ± 2.1% of cell viability after 36 hours of culture independently of serum supplemen-
tation. Thus, excluding a major proteomic confounding due to apoptotic vesicles in culture supernatants. It has 
also been emphasized that another factor affecting the quality of exosome preparations is the method of puri-
fication24; therefore, we purified HuRex by either UC25 or SEC26. The use of sequential centrifugation removing 
most apoptotic bodies (1,300 g pellet) and microvesicles (15,000 g pellet)25 and the use of SEC also removing these 
types of vesicles26, further emphasizes that we are mostly isolating exosomes derived from reticulocytes27. Due 
to intrinsic variability of human samples and the lack of a unique method for isolation of exosomes, however, we 
cannot exclude the possibility that a small number of these proteins are wrongly assigned to exosomes derived 
from reticulocytes.
HuRex were first subjected to Nanoparticle Tracking Analysis (NTA). Results demonstrated that HuRex were 
homogeneous with a mean size of 127 nm and that particle concentration was in the range of 108 particles/µL. 
Particle concentration from SEC fractions was always lower than that from UC (Fig. 1A). We determined the 
presence of the major component of Rex: the transferrin receptor, CD714,5,8 by beads-based flow cytometry. 
Higher MFI values for UC compared to those for SEC were always observed (Fig. 1B). To confirm vesicle integ-
rity, HuRex preparations obtained by UC were analyzed by transmission electron microscopy (TEM) by means 
Figure 1. Isolation and characterization of exosomes derived from human cord blood reticulocytes. (A) 
NTA profiles of HuRex from ultracentrifugation (UC) and size exclusion chromatography (SEC) fractions. 
Concentration is shown in particle/µL. (B) Flow cytometry analysis of transferrin receptor, CD71, in HuRex. 
MFI, Median Fluorescence Intensity. (C) Electron microscopy. Representative TEM image on the left. Bar 
represents 200 nm. Size distribution from TEM images quantified by ImageJ on the right. nm, nanometers.
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of negative staining (Fig. 1C). As expected from fixation and dehydration28, size distribution of TEM images 
revealed smaller vesicle mean size (70 nm), than that recorded by NTA (Fig. 1C).
Detection of the transferrin receptor on human reticulocyte-derived exosomes. The transferrin 
receptor is completely and selectively removed in exosomes during the terminal differentiation of reticulocytes 
into erythrocytes4,5,8. We first analyzed the presence of this protein by immunoblot in HuRex purified by UC and 
SEC (Fig. 2A and Supplementary Fig. S2). As expected from concentration of particles/µL (Fig. 1A), a higher 
signal was observed in the UC preparation as compared to SEC fractions. Next, immunoelectron microscopy 
demonstrated that TfR is associated with exosomes corroborating their reticulocyte origin (Fig. 2B).
Proteomic analysis of human reticulocyte-derived exosomes. Characterization by mass spec-
trometry, LC-MS/MS, was performed over HuRex from six different cord blood donors to determine their 
molecular composition. As research on the molecular cargo of exosomes is largely confounded by the lack of a 
“gold-standard” methodology24, we applied several approaches for obtaining HuRex prior to MS. HuRex prepa-
rations were obtained in absence of serum (AS) from three donors and isolated by means of SEC (n = 3) and 
UC (n = 3). HuRex preparations in the presence of serum were obtained from three other donors and purified 
by SEC (n = 3) and UC (n = 1). In total, 367 different proteins were identified in the 10 MS-dataset according 
to UniProt accessions, although protein numbers from each cord blood were different from each other due to 
the intrinsic variability of such samples (Supplementary Table S1). Nevertheless, most of the proteins identified 
by SEC are a subset of the ones identified by UC (not shown). Thus, after removal of leukocytes, the use of SEC 
and culturing of human reticulocytes from cord blood in the presence of serum, depleted of exosomes, seems a 
robust method for furthering studies of HuRex. To further verify the reticulocyte origin of exosomes4,5,8, we first 
demonstrated the presence of TfR in all MS-datasets (Supplementary Table S1). In addition, 45 unique peptides, 
including the sequence YTRFSLARQV previously shown to interact with hsc7029, and covering 64.08% of this 
receptor, were identified (Fig. 2C). Further western blotting analysis on these vesicles confirmed the detection 
of the raft-associated protein stomatin, previously associated to HuRex14 and verified the identification of newly 
detected proteins such as HSP70 and GAPDH (Fig. 3A and Supplementary Fig. S2).
Proteins were assigned different subcellular locations and percentages according to Gene Ontology (GO) 
annotation obtained from UniProt: Extracellular region (25.0%), Cytosol (15.9%), Plasma membrane (14.9%), 
Nucleus (13.5%), Cytoskeleton (5.9%), Lysosome (5.7%), Endosome (5.7%), Golgi apparatus(4.5%), Endoplasmic 
Figure 2. Detection of the transferrin receptor (TfR) in human reticulocyte-derived exosomes. (A) 
Immunoblot in HuRex purified by UC and SEC fractions. (B) Immunogold labelling of UC-HuRex using a 
secondary antibody conjugated to 10 nm-gold spheres. Scale bar represents 200 nm. (C) Protein coverage by 
unique peptides (grey boxes) identified by MS. The peptide sequence YTRFSLARQV, corresponding to the 
binding domain of TfR for hsc7142, is boxed in black. UniProtKB – P02786 TfR sequence is shown.
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reticulum (3.9%), Mitochondrion (3.4%), “Not retrieved” (1.1%) and Peroxisome (0.5%) (Fig. 3B and 
Supplementary Table S1). Of note, most of the proteins identified in this work were already listed in Vesiclepedia, 
a public data repository for extracellular vesicle cargo30 (Fig. 3C). Moreover, in agreement with these data, 
over-represention GO analysis of cellular component revealed that the bulk of proteins identified in HuRex corre-
spond to extracellular exosome (Fig. 3D and Supplementary Table S2). According to the idea that HuRex remove 
adhesins7,8, GO analysis of molecular function revealed protein binding as a major function of HuRex (Fig. 3D 
and Supplementary Table S2).
Biochemical analysis of exosomes obtained from sheep reticulocytes originally demonstrated that in addition 
to TfR several membrane enzymes and transporters were also selectively removed by exosomes6. Accordingly, 
we identified several of such and other membrane proteins, namely, Na+/K+ transporting ATPase (ATP1A1, 
ATP1B3), calcium-transporting ATPase (ATP2B4), neutral amino acid transporters (SLC1A5, SLC43A1, 
SLC7A5), and glucose transporters 1, 2, 3 and 4 (SLC2A1, SLC2A2, SLC2A3, SLC2A4). A notable exception was 
acetylcholinesterase which was reported to have high activity in the original description of exosomes6. Other 
MS studies of human reticulocytes and reticulocyte-derived exosomes from other species10,15 have also failed to 
detect this enzyme, but without other alternative method confirming its absence, we cannot rule out this is due 
Figure 3. Proteome of human reticulocyte-derived exosomes identified by LC-MS/MS. (A) Western blot 
validation for HSP70, GAPDH and stomatin on UC-HuRex. Samples were purified from two cord blood donors, 
each one loaded in a different lane. (B) Distribution of the proteome of HuRex in subcellular location categories 
retrieved from UniProt database according to Gene Ontology (GO) annotation. (C) Venn diagram showing 
the overlap of proteins detected in HuRex and those reported in Vesiclepedia, a database of extracellular vesicle 
cargo30. (D) GO term-enrichment analysis of HuRex proteome at cellular component and molecular function 
level performed with Database for Annotation, Visualization and Integrated Discovery (David 6.8)60. The most 
over-represented GO terms are shown.
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to technical issues. Several other plasma membrane proteins previously not reported in HuRex were identified in 
our analysis. These include several integrins alpha and beta (ITGA2B, ITGA4, ITGAM, ITGB1, ITGB2, ITGB3) 
and transporters (SLC6A9, SLC7A1) among others (Supplementary Table S1).
Previous functional enzymatic analyses of reticulocyte-derived exosomes revealed little or no activity of the 
cytosolic enzymes lactate dehydrogenase, glucose-6-phosphate dehydrogenase, glyceraldehyde-3-phosphate 
dehydrogenase, and 6-phosphogluconate dehydrogenase6. All these enzymes were identified in our MS anal-
ysis, albeit with different coverage and numbers of unique peptides (Supplementary Table S1). Of note, 
glyceraldehyde-3-phosphate is inactive when binding to band 331 but this explanation for the lack of activity 
was discarded as band 3 was not acknowledged to be present in reticulocyte-derived exosomes6. Yet, our studies 
identified band 3 suggesting this alternative explanation. Other cytosolic enzymes and proteins associated with 
HuRex are worth mentioning. Several Rab GTPases were identified, in particular Rab7a, Rab11b, and Rab14. In 
contrast, we failed to identify Rab27, known to play a main role in exosome biogenesis in other cells32. Similarly 
to acetylcholinesterase, further experimentation would be required to demonstrate its absence or by the contrary, 
prove its association to HuRex. We also detected five S100 proteins, calcium-modulated proteins pertaining to 
a vertebrate multigene family which in humans contain 24 members33. Notoriously, we identified S100-A9 with 
a coverage of 89.47%, a protein that has been recently found in plasma-derived exosomes associated to chronic 
lymphocytic leukemia34. We have identified several histones, including histone H4 previously shown to be largely 
exported to the cytoplasm15. Last, we and others15 failed to identified Tsg101, a major player in the biogenesis of 
exosomes in other cells35.
We crossed HuRex proteome with reported red cell MS proteomes from human reticulocytes15–17 and mature 
RBCs17–20. For that we first compared the cell proteomes (Supplementary Fig. S3) and we defined a reticulo-
cyte core proteome of 587 proteins and a mature RBC core proteome consisting of 1055 proteins. The inter-
section of HuRex proteins with the core proteomes of reticulocytes and matured RBCs (Supplementary Fig. S3 
and Supplementary Table S3) showed that many of the proteins identified in HuRex are also detected in these 
works, most of them associated to plasma membrane and cytosol (Supplementary Table S3). Moreover, when 
we performed a direct comparison of the proteins identified in HuRex with the mentioned human reticulo-
cyte proteomes15–17, around 70% of the proteins described in HuRex have been detected in their cell of origin 
(Supplementary Fig. S3).
Even though in this first MS proteomic description of HuRex we focused on protein identification, we cal-
culated the normalized spectral abundance factor (NSAF)36 (one of the most common protein quantification 
indexes used in label-free quantificacion proteomics based on the spectral counting)37 to estimate relative protein 
abundance. We observed that previously detected proteins in HuRex such as TfR and stomatin, as well as newly 
identified like S100A9 and HSPA8 were found among the 50 most abundant proteins (Supplementary Fig. S4 and 
Supplementary Table S5).
Capture of HuRex by dendritic cells. MHC class-I molecules are involved in antigen presentation where 
professional antigen presenting cells such as dendritic cells are usually required to process and present antigens 
to T cells2. As we detected HLA class-I antigens in HuRex and our own previous results demonstrated the pres-
ence of MHC class-I molecules in exosomes from rodent malaria infections11,12, we decided to run a functional 
assay to determine if HuRex could be uptaken by dendritic cells (DCs). This assay had previously demonstrated 
that the sialic acid-binding Ig-like lectin 1, Siglec-1, is responsible for exosome capture on mature DCs and fol-
lows the same trafficking route as HIV-1 particles38,39. Flow cytometry analysis revealed that 19 ± 8% of acti-
vated monocyte-derived dendritic cells (mDCs) actively uptake HuRex labeled with Dil (HuRexDiI) (Fig. 4A). We 
next assessed if HuRexDiI were retained within the same sub-cellular compartment as fluorescent HIV-1 VLP. As 
shown in Fig. 4B and Video 1, mDCs exposed to HuRexDiI and subsequently exposed to HIV-1 VLP retained both 
types of vesicles within the same sack-like compartment, as analyzed by confocal microscopy. Last, pretreatment 
of mDCs with a monoclonal antibody against Siglec-1 significantly inhibited HuRexDiI capture, T-test P < 0.05 
(Fig. 4C). Thus, HuRex are efficiently captured by mDCs via Siglec-1.
Discussion
Here, we present the first mass spectrometry-based proteomic analysis of human reticulocyte-derived exosomes 
(HuRex) consisting of 367 proteins. Previously, MS proteomes from human reticulocytes15–17, and mature RBCs17–20, 
had been reported. When comparing this novel HuRex proteome with those proteomes, we found many common 
proteins, especially from plasma membrane and cytosol (Supplementary Fig. S3 and Supplementary Table S3). 
These data are largely in agreement with the idea that exosomes reflect a “cell biopsy”, but at the same time are 
enriched in specific cargo1,40. In addition, the complete MS proteome of reticulocyte-derived exosomes from 
rats is available10 and its comparison with the HuRex proteome revealed more than 200 conserved proteins 
(Supplementary Table S4). This dataset thus represents the first comprehensive list of proteins from human 
reticulocyte-derived exosomes and a valuable resource to pursue different studies (Fig. 5).
The endocytic pathway in reticulocytes differs from other cells as lysosomes are almost completely absent. 
Moreover, as a Golgi apparatus and an endoplasmic reticulum are also vestigial, it is reasonable to think that com-
plex and diverse sorting pathways are absent from reticulocytes. Thus, the final step in this differentiation should 
be considered the MVB-exosomal release41. Elegant studies on the fate of the TfR during reticulocytes maturation 
using rodent and sheep models demonstrated that this receptor specifically interacts with the heat shock cognate 
70 kDa protein29. Moreover, it was later shown that the hydrophobic peptide sequence YTRFSLARQV containing 
basic amino acids within the cytosoloic domain of TfR represented the binding domain of hsc7042. However, 
when inhibitors of hsc70 were added to the binding assays, secretion of TfR was not affected indicating that TfR/
hsc70 interactions were not the signal for sorting of TfR into exosomes. Rather, in these same studies, Alix a 
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well-known protein involved in the biogenesis of exosomes from other cells, was also shown to interact with the 
YTRF motif suggesting a contribution to TfR exosomal sorting. In addition, it was shown that sorting of TfR was 
concomitant with proteosomal degradation of abundant cytosolic proteins via AP2 complexes.
Figure 4. Siglec-1 dependent capture of human reticulocyte-derived exosomes by mature dendritic cells. (A) Flow 
cytometry analysis of HuRexDiI capture by mDCs. (B) Confocal microscopy co-localization of HuRexDiI (in red) and 
VLPHIV-Gag-eGFP (in green) in mDCs (nuclei stained with DAPI). Top: z-plane showing fluorescence and bright field 
(scale bar 5 μm); Bottom: 3D reconstruction of z-planes (reference scale unit 2,48 μm). (C) Inhibition of HuRexDiI 
capture by mDCs by blocking of Siglec-1 with α-Siglec-1 mAb. mDCs not treated with antibodies nor with HuRexDiI 
were incubated in parallel (C neg). Data show mean values and SD from 2 donors. T-test P < 0.05.
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Our MS analysis revealed the presence of TfR, including the sequence YTRFSLARQV, hsc71 protein (another 
name for hsc70) and Alix whereas abundant cytosolic proteins were absent. It therefore seems that similar mech-
anisms operate in the biogenesis and sorting of human reticulocyte-derived exosomes excepting for Tsg101 which 
is not present in human reticulocytes15 neither in our analysis. Last, Galectin 5 is a rat-specific protein involved in 
an ESCRT-independent sorting pathway of some glycosylated proteins43. We identified Galectin 3 binding protein 
in our dataset. Whether it has a similar function as Galectin 5 remains to be determined.
Reticulocyte-derived exosomes from experimental infections of mice with a reticulocyte-prone rodent 
malaria parasite contain parasite antigens and MHC class-I molecules12. Moreover, when used in immuniza-
tions, they were able to confer full and long-lasting protection upon lethal challenges as well as eliciting effector 
memory T cells11. Noticeably, we identified HLA class-I antigens in HuRex and our own unpublished results 
have also identified HLA class-I antigens and parasites antigens in plasma-derived exosomes from malaria 
patients. Elegant studies on the mechanism of antigen-specific T cell stimulation by peptide-bearing exosomes 
demonstrated activation of T cell proliferation mainly in the presence of mature dendritic cells44. We thus used 
a functional assay38 to demonstrate the potential capacity of HuRex to interact with dendritic cells as they play a 
pivotal role in antigen presentation in natural malarial human infections45. This assay previously demonstrated 
that ganglioside-containing vesicles such as viral-like particles or exosomes could be captured by mature den-
dritic cells expressing Siglec-139. Noticeably, our results demonstrated Siglec-1-dependent specific capture of 
HuRex by mDCs as well as co-localization of HuRex with VLPs (Fig. 4). These data suggest that in addition 
of a “garbage-disposal” mechanism for the terminal differentiation of reticulocyte to erythrocytes, HuRex can 
facilitate antigen presentation via dendritic cells in the context of a human infection with a unique tropism for 
reticulocytes.
Figure 5. The human reticulocyte-derived exosome proteome. Schematic illustration of a human reticulocyte-
derived exosome highlighting selected plasma membrane and cytosolic proteins. Transporters (in orange): 
Na+/K+ transporting ATPase (ATP1A1, ATP1B3), H+/Cl− exchange transporter 3 (CLCN3), Plasma 
membrane calcium-transporting ATPase 4 (ATP2B4), Neutral amino acid transporters (SLC1A5, SLC43A1, 
SLC7A5), Glucose transporters 1, 2, 3 and 4 (SLC2A1, SLC2A2, SLC2A3, SLC2A4), Na+/Cl− dependent 
glycine transporter 1 (SLC6A9), High affinity cationic amino acid transporter 1 (SLC7A1) and Aquaporin-1 
(AQP1). Adhesins (in lime): Integrin alpha and beta (ITGA2B, ITGA4, ITGAM, ITGB1, ITGB2, ITGB3), CD36 
and CD44. Other membrane proteins (in brown): Lysosome-associated membrane glycoprotein 2 (LAMP2) and 
CD59 glycoprotein (CD59). Antigen presentation (in grey): HLA class I antigens (HLA-A, HLA-C). RABs (in 
pink): RAB7A, RAB11B and RAB14. Biogenesis (in green): Transferrin receptor protein 1 (TFRC), Heat shock 
70 kDa protein (HSPA8, HSPA1A) and Alix (PDCD6IP). Cytosolic proteins (in blue): Histone H4 (HIST1H4A), 
Lactate dehydrogenase (LDHA, LDHB), Glucose-6-phosphate dehydrogenase (G6PD), Glucose-6-phosphate 
isomerase (GPI), Glyceraldehyde-3-phosphate dehydrogenase (GAPDH), 6-phosphogluconate dehydrogenase 
(PGD), Catalase (CAT) and Transketolase (TKT). Red cell diseases and malaria (in red): Transferrin receptor 
protein 1 (TFRC), CD98 (SLC3A2, SLC7A5), S100A9, Band 3 anion transport protein (SLC4A1), Erythrocyte 
band 7 integral membrane protein (STOM) and Flotillins 1 and 2 (FLOT1, FLOT2). Proteins in bold have been 
previously described in human reticulocyte-derived exosomes (TfR, STOM, CD59)7,13,14.
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Studies on the role of extracellular vesicles, including exosomes, in red cell diseases are just beginning but 
already promise to shed light into mechanistic insights of pathology and in identifying non-invasive biomarkers46. 
For instance, in sickle cell disease (SCD), a group of inherited cell disorders, as well as in thalassemias, charac-
terized by abnormal haemoglobin production, studies on the levels of platelets and red blood cells microparticles 
revealed an elevated level as opposed to normal individuals47,48. Moreover, a casuistic association on the abnormal 
presence of α4β1 integrin in circulating red blood cells leading to vascular obstruction in patients with SCD has 
been observed49. Human malaria caused by Plasmodium vivax, a parasite with a unique tropism for reticulo-
cytes, is a red cell disease inducing inducing hemolytic anemia upon infections50. Knowledge on this parasite and 
disease have been hampered due to the lack of a continuous in vitro culture system. Our data shows that several 
receptors and proteins involved in entrance of the parasite into the host cell, such as CD9851, CD7152, band 353 and 
erythrocyte band 754, are selectively removed in HuRex. Remarkably, a recent report provides the first direct evi-
dence of the role of exosomes in erythroid diseases. It was shown that the S100-A9 protein associated to exosomes 
represent a new pathway for NF-κβ activation in chronic lymphocytic leukemia cells34. In addition, extracellular 
vesicles in hematological malignancies have been stood out not only as promoters of tumor aggressiveness, but 
also as a valuable source of biomarkers for diagnosis55. Further studies on extracellular vesicles, including HuRex, 
in the context of red cell diseases are warranted.
In conclusion, this work opens new avenues for furthering studies of human reticulocyte-derived exosomes: 
firstly, on their biogenesis as most of the data presently available on this subject are from other species; secondly, 
on the possibility that HuRex can present pathogen-peptide antiges via dendritic cells inducing T cell responses; 
thirdly, on guiding new approaches to develop a continuous in vitro culture system for P. vivax; fourthly, on 
comparative analysis of the molecular composition of reticulocyte-derived exosomes from plasma or other body 
fluids in patients with difficulty to diagnose red cell diseases thus providing an alternative for identifying novel 
biomarkers. Last but not least, as quoted elsewhere8, perhaps Rose Johnstone was right: after having been a curi-
osity for many years, we might be at the doorstep of recognizing the potential of reticulocyte-derived exosomes.
Materials and Methods
Purification of human reticulocytes. Human cord blood samples were obtained from the Blood and 
Tissue Bank of Barcelona (https://www.bancsang.net/) in accordance with the Good Clinical and Laboratory 
Practice Guidelines, the Declaration of Helsinki, and local rules and national regulations. The protocol, includ-
ing the informed consent forms, has been approved by the Clinical Research Ethics Committee of Vall d’He-
bron University Hospital (PR(CS)236/2017). Briefly, similarly to a previous work56, 70 mL of cord blood were 
centrifuged at 1000 g for 15 min. After removal of plasma, the pelleted cells were washed and re-suspended at 
50% hematocrit with RPMI-1640 medium (Sigma). Leukocytes and platelets were removed by filtration through 
columns of cellulose powder (Whatman), previously packed with 10 mL of cellulose, irradiated with ultraviolet 
light for sterilization and washed with a double volume of RPMI medium immediately before their use. Filtrated 
blood was washed twice with RPMI medium and adjusted to 50% hematocrit. 5 mL aliquots of blood were care-
fully layered on 6 mL 70% Percoll (Healthcare). After centrifugation at 1200 g for 15 min at 20 °C, concentrated 
reticulocytes in the Percoll interface were carefully collected and washed twice with RPMI medium. Reticulocyte 
quantification was performed by examination of brilliant cresyl blue (BCB)/Giemsa stained thin blood films57. 
Only samples with >20% reticulocyte-enrichments and <2% leukocytes were used for HuRex production. We 
routinely obtained in the order of 108 reticulocytes per 70 mL of cord blood.
In vitro production and isolation of human reticulocyte-derived exosomes. Reticulocytes were 
cultured for 36 h at 37 °C and 1–3% hematocrit in RPMI medium, not supplemented or supplemented with 0.5% 
of human AB serum, previously depleted of exogenous exosomes. Viability of reticulocytes was assessed using 
Trypan Blue stain 0.4% (Sigma, 93595). Cell-free post-culture supernatants were collected by centrifugation at 
1,300 g for 20 min at 20 °C. To isolate Rex, 2 mL of culture supernatants were loaded on 10 mL-sepharose CL-2B 
(Sigma) size-exclusion chromatography (SEC) columns26, where fractions of 500 µL were collected. Alternatively, 
6–10 mL of culture supernatants were subjected to sequential centrifugation at 4 °C for 15,000 g/45 min and UC at 
100,000 g/90 min25, where exosome pellets were resuspended in 200 µL of PBS. Protein content of SEC fractions 
and UC samples was determined by Nanodrop® ND-1000 and BCA assay (Thermo Scientific).
Nanoparticle tracking analysis (NTA). Size distribution and concentration of exosomes were determined 
by NTA using a NanoSight LM10 instrument (Malvern Instruments Ltd) as described26. Data were analyzed with 
NTA software (version 3.1).
Bead-based flow cytometry. SEC fractions enriched in exosomes were identified by bead-based flow 
cytometry25,26 assessing the presence of the transferrin receptor, CD71, a major component of Rex4,5,8. UC sam-
ples were similarly analyzed to warrant the presence of this marker. Briefly, SEC fractions and UC samples were 
coupled to 4 µm-aldehyde/sulfate-latex beads (Invitrogen) for 15 min at RT. Beads were then resuspended in 
1 mL of bead-coupling buffer (BCB: PBS with 0.1% BSA and 0.01% NaN3) and incubated overnight at RT on 
rotation. Exosome-coated beads were then centrifuged at 2,000 g for 10 min at RT, and washed once with BCB 
prior to incubation with anti-CD71 (ab84036) at 1:1,000 dilution for 30 min at 4 °C. After washing with BCB, 
exosome-coated beads were incubated for 30 min at 4 °C with Alexa Fluor 488-conjugated anti-rabbit IgG sec-
ondary antibody (Invitrogen, A-11008) at 1:100 dilution. Coated beads incubated with secondary antibodies 
were used as a control. Labelled exosome-beads were washed twice with BCB before being finally resuspended in 
PBS and subjected to flow cytometry (FacsVerse; BD). Flow Jo software was used to compare mean fluorescence 
intensity (MFI) of exosome-coated beads.
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Immunoblot analysis. Ten µL aliquots of either a UC preparation or individual SEC fractions were analyzed 
by Western blot against human CD71. Membranes were probed with rabbit polyclonal anti-CD71 (ab84036) 
at 1:250 dilution for 1 hour at RT. A goat anti-rabbit IgG coupled to HRP (Sigma, A6154) was used at a dilu-
tion of 1:2,500 for 1 hour at RT. Revealing was performed using ECL Western Blotting Substrate (Pierce™) in 
ImageQuant LAS 4000 (GE Healthcare Life Sciences). Additionally, 20 µL aliquots of UC preparations were ana-
lyzed to confirm the presence of HSP70, GAPDH and stomatin in HuRex. Membranes were incubated for 1 hour 
at RT with primary antibodies anti-HSP70 (Santa Cruz Biotechnology, W27 sc-24) at 1:250 dilution, anti-GAPDH 
(Sigma, G9545) at 1:500 dilution or anti-stomatin (Invitrogen, PA5-30019) at 1:250 dilution. Subsequently, mem-
branes were washed and incubated for 1 h at RT with the Li-Cor IRDye-labeled secondary antibodies IRDye® 
800CW goat-anti-mouse (925-32210, Li-Cor Biosciences) at 1:15,000 dilution or IRDye® 680RD goat anti-rabbit 
(925-68021, Li-Cor Biosciences) at 1:20,000 dilution. Blots were analyzed with the Odyssey near-infrared system 
(Li-Cor Biosciences) having the intensity of 700 channel set up at 5 and the one of 800 channel at 7. Images were 
edited using the software Image J (NIH).
Transmission electron microscopy (TEM). TEM was performed over HuRex UC preparations negatively 
stained as previously detailed12. Preparations were analyzed with a Jeol JEM-1100 TEM (Jeol Ltd, Tokyo, Japan) 
equipped with a Gatan Ultrascan ES1000 CCD Camera. Immunogold labeling was performed as detailed else-
where26 with anti-CD71 (ab84036).
HuRexDiI generation. Reticulocyte-enriched RBCs were labeled with DiI (Molecular Probes, V-22885) 
following manufacturer’s instructions. Culture of stained cells and exosome isolation was performed as for the 
unstained HuRex. Fluorescence of HuRexDiI was determined by a Fluoroskan Ascent FL fluorimeter (Thermo 
Fisher Scientific).
Exosome and VLP capture by mature monocyte-derived DCs via Siglec-1. 2 × 105 LPS-matured 
monocyte-derived DCs (mDCs) were obtained as previously described38 and incubated with 50 μg HuRexDiI at 
37 °C for 4 hours. Cells were washed and acquired with a BD FACSCalibur™ cytometer. Data were analyzed 
using FlowJo software. For microscopy analysis, mDCs were pulsed for 24 h with HuRexDiI and then with 150 μg 
of fluorescent viral-like particles containing Gag-enhanced green fluorescent (VLPHIV-Gag-eGFP) for 3 additional 
hours at 37 °C. Cells were washed, fixed, cytospun into coverslips, mounted with DAPI mounting media (Thermo 
Fisher Scientific) and analyzed with an Ultraview ERS Spinning Disk System (Perkin-Elmer) mounted on a Zeiss 
Axiovert 200 M inverted microscope. Volocity software (Perkin-Elmer) was used to analyze microscopy images.
To determine whether Siglec-1 could represent a receptor for entrance of HuRex, mDCs were pre-incubated 
with 10 µg/mL of an anti-Siglec-1 monoclonal antibody (clone 7–239; Abcam) or a mouse anti-human IgG1 iso-
type control (BD) at RT for 15 min39 before addition of 50 μg HuRexDiI at 37 °C for 4 hours. Capture was analyzed 
by flow cytometry as described above.
Mass spectrometry. Liquid chromatography (nanoLCULTRA-EKSIGENT) followed by mass spectrometry 
(LC-MS/MS) on a LTQ Orbitrap Velos (Thermo Fisher Scientific) was performed following our own procedures26. 
To increase exosomal protein coverage, some samples (CB30_PS_SEC; CB30_PS_UC; CB31_AS_SEC; CB31_AS_UC) 
were extracted with RIPA buffer and digested with Lys-C in addition to Trypsin digestions.
Protein identification and in silico analysis. Mass spectrometry data were processed by Mascot v2.5.1 
(Matrix Science) using the human sequences from the UniProt-Swiss-prot database (release April 2017) with a 
false-discovery rate below 1%. Proteins identified by a unique peptide were only accepted if present in two or 
more samples. Keratins and keratin-associated proteins as well as potential serum contaminants were removed 
from the final list of proteins (Supplementary Table S1). We considered as serum contaminants the classical 
plasma proteins described by Anderson and Anderson proteomics58 as well as other protein components com-
piled in this work that were exclusively detected in HuRex preparations from serum-supplemented cultures. The 
MS proteomics data have been deposited to the ProteomeXchange Consortium via the PRIDE partner repository 
with the dataset identifier PXD00854559.
We estimated relative protein abundance calculating the normalized spectral abundance factor (NSAF) as 
described elsewhere36. This protein quantification index was established considering all proteins identified prior 
to filtering with their corresponding number of peptide spectrum matches.
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